<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="109168">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01780064</url>
  </required_header>
  <id_info>
    <org_study_id>APAPI-1202</org_study_id>
    <nct_id>NCT01780064</nct_id>
  </id_info>
  <brief_title>Early Individualized Psychosocial Assets to Facilitate the Return to Employment of Women With Breast Cancer</brief_title>
  <acronym>APAPI</acronym>
  <official_title>Early Individualized Psychosocial Assets to Facilitate the Return to Employment of Women With Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Oscar Lambret</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Oscar Lambret</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé</authority>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of early individualized psychosocial
      assets versus a standard support on social inequalities in the rate of return to work
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For the group &quot;intervention&quot;, patients have four interviews with a psychologist (at cure one
      of chemotherapy treatment, at cure six of chemotherapy treatment, at last radiotherapy
      session, and three months after the end of radiotherapy).

      In the 2 arms, patients receive 4 sets of questionnaires (baseline, month 12, month 18 and
      month 24)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Comparison of the effect of early individualized psychosocial assets versus a standard support on social inequalities in the rate of return to work</measure>
    <time_frame>At 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison between the two modes of care, social inequalities and calculating the cost / benefit ratio of the two modes of care</measure>
    <time_frame>At 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Standard group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>routine monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Interviews with psychologist</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients have interviews with a psychologist (at cure one of chemotherapy treatment,at cure six of chemotherapy treatment, at last radiotherapy session, and three months after the end of radiotherapy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>interviews with a psychologist</intervention_name>
    <arm_group_label>Interviews with psychologist</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaires</intervention_name>
    <arm_group_label>Standard group</arm_group_label>
    <arm_group_label>Interviews with psychologist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women ≥ 18 with work at the time of diagnosis

          -  Presenting a unilateral breast cancer exclusively local extension

          -  Having received surgery

          -  Reporting of adjuvant chemotherapy (+ / - trastuzumab)

          -  Reporting to radiotherapy or not (If radiotherapy, it will be done on site
             investigator)

          -  In work at the time of diagnosis (employees, traders and professionals)

          -  Patient affiliated to a social security scheme

          -  Consent signed by the patient before the implementation of any specific procedure to
             study

        Exclusion Criteria:

          -  Presence of in situ lesions, cancer recurrence, metastatic disease immediately,
             location bilateral

          -  Inability physical, psychological, psychiatric or cognitive responses to the
             questionnaires and participate in interviews

          -  Recognition previous ALD (due to another disease)

          -  Patient under guardianship
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sophie FANTONI, Pr</last_name>
    <phone>+33(0)3 20 44 57 94</phone>
    <email>fanquin@wanadoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Pierre Curie</name>
      <address>
        <city>Arras</city>
        <zip>62000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Marie Curie</name>
      <address>
        <city>Arras</city>
        <zip>62000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Léonard de Vinci</name>
      <address>
        <city>Dechy</city>
        <zip>59187</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olimpia OLSZYK, Dr</last_name>
      <phone>+33(0)3 27 08 60 60</phone>
      <email>olimpiaolszyk@gmail.om</email>
    </contact>
    <investigator>
      <last_name>Olimpia OLSZYK, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Damien CARLIER, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franck DARLOY, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire GIRAUD, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie POTTIER, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas REZVOY, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques BONNETERRE, Pr</last_name>
      <phone>+33 (0)3 20 29 59 18</phone>
      <email>j-bonneterre@o-lambret.fr</email>
    </contact>
    <investigator>
      <last_name>Jacques BONNETERRE, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurence VANLEMMENS, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique SERVENT, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey MAILLIEZ, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emilie LE RHUN, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nouvelle Clinique des Dentellières</name>
      <address>
        <city>Valenciennes</city>
        <zip>59300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Valenciennes</city>
        <zip>59300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 17, 2014</lastchanged_date>
  <firstreceived_date>January 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
